University of Vermont

College of Medicine

Department of Surgery

Bio for Thomas Ahern, PhD, MPH
Thomas Ahern, PhD, MPH

Thomas Ahern, PhD, MPH

Assistant Professor of Epidemiology
Division of Surgical Research
Department of Surgery


Contact Information
E-mail: Thomas.Ahern@med.uvm.edu
Office Location:
Surgery, Given Rm D317A

Education

M.P.H., Epidemiology, Boston University, Boston, MA. 2006
Ph.D., Epidemiology, Boston University, Boston, MA. 2010
Post-Doctoral Research Fellow, Cancer Epidemiology, Harvard School of Public Health. 2010 - 2012

Academic Appointments

Assistant Professor, Department of Surgery, University of Vermont College of Medicine. 2013 - present
Instructor, Department of Medicine, Harvard Medical School. 2011 - 2012
Visiting Fellow Department of Clinical Epidemiology, Aarhus University, Denmark. 2012-2013 
Associate Epidemiologist, Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital. 2012 - 2013

Awards and Honors

Fred F. Kadlubar Memorial Scholar-in-Training Award, American Association for Cancer Research. 2011  
Best Presentation by a Post-Doctoral Fellow,  Harvard School of Public Health. 2011  
Scholar-in-Training Award, Molecular Epidemiology Working Group,  American Association for Cancer Research. 2012  
Clinical Research Student Loan Repayment Program, National Institutes of Health. 2012  

Publications

Ahern TP, Tamimi RM, Rosner BA, Hankinson SE. Digoxin use and risk of invasive breast cancer: evidence from the Nurses' Health Study and meta-analysis. Breast Cancer Res Treat 2014 Apr;144(2):427-35.

Cronin-Fenton DP, Christensen M, Lash TL, Ahern TP, Pedersen L, Garne JP, Ewertz M, Autrup H, Sørensen HT, Hamilton-Dutoit S. Manganese superoxide dismutase and breast cancer recurrence: a Danish clinical registry-based case-control study, and a meta-analysis. PLoS One. 2014 Jan 31;9(1):e87450.

Ahern TP, Hankinson SE, Willett WC, Pollak MN, Eliassen AH, Tamimi RM. Plasma C-peptide, mammographic breast density, and risk of invasive breast cancer. Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1786-96.

Sørensen GV, Ganz PA, Cole SW, Pedersen LA, Sørensen HT, Cronin-Fenton DP, Garne JP, Christiansen PM, Lash TL, Ahern TP. Use of ß-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study. J Clin Oncol. 2013 Jun 20;31(18):2265-72.

Lash TL, Ahern TP. Bias analysis to guide new data collection. Int J Biostat. 2012;8(2):4679.

Cronin-Fenton DP, Hellberg Y, Lauridsen KL, Ahern TP, Garne JP, Rosenberg C, Silliman RA, Sørensen HT, Lash TL, Hamilton-Dutoit S. Factors associated with concordant estrogen receptor expression at diagnosis and centralized re-assay in a Danish population-based breast cancer study. Acta Oncol. 2012 Feb;51(2):254-61.

Ahern TP, Pedersen L, Sværke C, Rothman KJ, Sørensen HT, Lash TL. The association between vitamin K antagonist therapy and site-specific cancer incidence estimated by using heart valve replacement as an instrumental variable. Am J Epidemiol. 2011 Dec 15;174(12):1382-90.

Ahern TP, Pedersen L, Tarp M, Cronin-Fenton DP, Garne JP, Silliman RA, Sørensen HT, Lash TL. Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study. J Natl Cancer Inst. 2011;103(19):1461-8.

Ahern TP, Christensen M, Cronin-Fenton DP, Lunetta KL, Søiland H, Gjerde J, Garne JP, Rosenberg CL, Silliman RA, Sørensen HT, Lash TL, Hamilton-Dutoit S. Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivors. Cancer Epidemiol Biomarkers Prev. 2011 Sep;20(9):1937-43.

Publications in PubMed